These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10227098)

  • 41. [Therapeutic strategies in rheumatoid arthritis].
    Bastian H; Feist E; Burmester GR
    Internist (Berl); 2011 Jun; 52(6):645-56. PubMed ID: 21590474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Current concepts of pharmacotherapy in rheumatoid arthritis].
    Balabanova RM
    Vestn Ross Akad Med Nauk; 2003; (7):19-23. PubMed ID: 12934465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination therapy in early rheumatoid arthritis.
    Gossec L; Dougados M
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S174-8. PubMed ID: 14969072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
    Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M;
    J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From aspirin to biologics: therapeutic implications for rheumatoid arthritis.
    Wright V
    J Rheumatol Suppl; 1992 Jan; 32():95-7. PubMed ID: 1613740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Update on the use of steroids in rheumatoid arthritis.
    García-Magallón B; Silva-Fernández L; Andreu-Sánchez JL
    Reumatol Clin; 2013; 9(5):297-302. PubMed ID: 23726772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions.
    Bays AM; Gardner G
    Med Clin North Am; 2016 Jul; 100(4):719-31. PubMed ID: 27235612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
    Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
    J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early Diagnosis and Treatment of Rheumatoid Arthritis.
    Littlejohn EA; Monrad SU
    Prim Care; 2018 Jun; 45(2):237-255. PubMed ID: 29759122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How may quality of life for rheumatoid arthritis patients be enhanced by current and future treatments?
    Fries JF
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():35-40. PubMed ID: 10646489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
    Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
    Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Challenging the pyramid. A new look at terapeutic approaches for rheumatoid arthritis. Patient selection.
    Katz WA
    J Rheumatol Suppl; 1990 Nov; 25():39-41. PubMed ID: 1980315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS
    Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Early rheumatoid arthritis--rapid help is double help].
    Aringer M; Leuchten N; Machold KP
    Z Rheumatol; 2007 Dec; 66(8):693-701; quiz 702. PubMed ID: 18034251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A history of the term "DMARD".
    Buer JK
    Inflammopharmacology; 2015 Aug; 23(4):163-71. PubMed ID: 26002695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review.
    Kuijper TM; Lamers-Karnebeek FB; Jacobs JW; Hazes JM; Luime JJ
    J Rheumatol; 2015 Nov; 42(11):2012-22. PubMed ID: 26428204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis.
    Rannio T; Asikainen J; Kokko A; Hannonen P; Sokka T
    J Rheumatol; 2016 Apr; 43(4):699-706. PubMed ID: 26879355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current concepts in the management of rheumatoid arthritis.
    Tanaka Y
    Korean J Intern Med; 2016 Mar; 31(2):210-8. PubMed ID: 26932398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.